Panthera Biopartners currently works with multiple vendors, GP practices and NHS trusts across the country. We have a number of ways in which we partner with companies and institutions that have excellent benefits for you and your patients.
Value through partnership
Panthera is focussed on providing its clients, CROs and Pharma, with the best cost-effective solution for each trial.
Through partnering Panthera can agree on an early start patient enrolment programme. Each site can enrol many patients dramatically reducing the cost of commissioning large numbers of small sites, 50 % of which recruit one patient or less.
Risk sharing so that Panthera’s performance is tied to its remuneration.
Speeding up clinical trials can save billions
Panthera’s SMOs model reduces start-up for a phase 2 or Phase 3 clinical trial by up to nine months compared to UK public sites.
Panthera is already identifying likely patients seven months before the public sector sites start planning their recruitment campaigns.
Panthera aims to agree contract terms in as short as one month.